Treatment of pediatric-onset relapsing-remitting multiple sclerosis with high-efficacy therapy reduces the risk for transition across disability states, according to a study published in the May issue ...

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not ...

Wearable sensors may help identify people with multiple sclerosis (MS) who are more likely to have worsening disability and loss of brain volume, according to a study published in Neurology. The study ...

Serum neurofilament light chain (NfL) elevation -- a sign of accelerated neuroaxonal injury -- appeared about 1 year before disability worsening events associated with relapses in multiple sclerosis ...

In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a new study. The study ...

Please provide your email address to receive an email when new articles are posted on . A study followed more than 3,000 adults for up to 15 years post-MS diagnosis. Obesity was associated with ...

Pregnancy was not linked with long-term disability outcomes in women with moderately severe multiple sclerosis (MS), registry data suggested. There was no significant difference in time to 6-month ...